索拉非尼
血管生成
PI3K/AKT/mTOR通路
癌症研究
肝细胞癌
细胞凋亡
蛋白激酶B
化学
医学
生物化学
作者
Tohada M. AL‐Noshokaty,Noha M. Mesbah,Dina M. Abo‐Elmatty,Ahmed I. Abulsoud,Asmaa R. Abdel-Hamed
出处
期刊:Life Sciences
[Elsevier]
日期:2022-05-28
卷期号:303: 120675-120675
被引量:78
标识
DOI:10.1016/j.lfs.2022.120675
摘要
SOR/SeNps are a promising combination for tumor suppression and overcoming sorafenib resistance in HCC by modulating apoptosis, AKT/mTOR and NF-κB pathways, as well as CD34 and lncRNA-AF085935/GPC3 axis.
科研通智能强力驱动
Strongly Powered by AbleSci AI